BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 22045184)

  • 21. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients.
    Pehalova L; Krejci D; Halamkova J; Smardova L; Snajdrova L; Dusek L
    Cancer Epidemiol; 2021 Jun; 72():101929. PubMed ID: 33819838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incidence of and mortality from leukaemias in the UK: a general population-based study.
    Bhayat F; Das-Gupta E; Smith C; McKeever T; Hubbard R
    BMC Cancer; 2009 Jul; 9():252. PubMed ID: 19630999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of socio-economic deprivation on burn injury: A nine-year retrospective study of 6441 patients.
    Marsden NJ; Battle CE; Combellack EJ; Sabra A; Morris K; Dickson WA; Whitaker IS; Evans PA
    Burns; 2016 Mar; 42(2):446-52. PubMed ID: 26797151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematological malignancies in the Northwest Ethiopia.
    Enawgaw B; Aynalem M; Melku M; Asrie F; Abebe M; Yalew A; Bekele T; Mesfin N; Ayalew M; Shiferaw E
    PLoS One; 2021; 16(12):e0260639. PubMed ID: 34852010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
    Lin YC; Yen JH; Chang SJ; Lin YC
    Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival following relapse in childhood haematological malignancies diagnosed in 1974-2003 in Yorkshire, UK.
    Feltbower RG; Kinsey SE; Richards M; Shenton G; Michelagnoli MP; McKinney PA
    Br J Cancer; 2007 Apr; 96(7):1147-52. PubMed ID: 17342086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of bacteraemia and mortality in patients with haematological malignancies.
    Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
    Clin Microbiol Infect; 2006 Mar; 12(3):217-23. PubMed ID: 16451407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.
    Murphy F; Kroll ME; Pirie K; Reeves G; Green J; Beral V
    Br J Cancer; 2013 Jun; 108(11):2390-8. PubMed ID: 23640394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of haematological malignancies in French Polynesia between 1990 and 1995.
    Roda L; de Vathaire F; Rio B; Le Tourneau A; Petididier P; Laudon F; Zittoun R
    Leuk Res; 1999 Apr; 23(4):349-55. PubMed ID: 10229320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network.
    Sheridan R; Roman E; Smith AG; Turner A; Garry AC; Patmore R; Howard MR; Howell DA
    BMJ Support Palliat Care; 2021 Mar; 11(1):7-16. PubMed ID: 32393531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.
    Roman E; Kane E; Howell D; Lamb M; Bagguley T; Crouch S; Painter D; Patmore R; Smith A
    Int J Epidemiol; 2022 Jun; 51(3):e87-e94. PubMed ID: 35134983
    [No Abstract]   [Full Text] [Related]  

  • 34. The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.
    Dandoit M; Mounier M; Guy J; Petrella T; Girard S; Casasnovas RO; Martin L; Bonnetain F; Maynadié M
    Leuk Lymphoma; 2015 Apr; 56(4):1050-7. PubMed ID: 25166007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland.
    Lindström V; Aittoniemi J; Lyytikäinen O; Klemets P; Ollgren J; Silvennoinen R; Nuorti JP; Sinisalo M
    Infect Dis (Lond); 2016; 48(5):399-402. PubMed ID: 26635103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence.
    Broccia G; Deplano W; Dessalvi P; Giannico B; Luxi G; Chessa E; Murru A
    Hematol Oncol; 2004 Sep; 22(3):91-109. PubMed ID: 15991220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Haematological malignancies (HM) in Basse-Normandie (BN): incidence and clinical and biological characteristics over the period 1997-2005 in patients less than 25 years old].
    Collignon A; Duchenet V; Mouchel D; Malet M; Cornet E; Troussard X
    Rev Epidemiol Sante Publique; 2012 Oct; 60(5):343-53. PubMed ID: 22981308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.